Piperacillin And Tazobactam And Sodium Chloride Injection, Solution
NDC Package 0264-3446-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Piperacillin And Tazobactam And Sodium Chloride injection is the usual total daily dosage of Piperacillin and Tazobactam for Injection and Sodium Chloride Injection for adult patients with indications other than nosocomial pneumonia is 3.375 g every 6 (six) hours, to be administered by intravenous infusion over 30 minutes. This formulation utilizes a injection, solution delivery system. Marketed by B. Braun Medical Inc., this product is identified by NDC 0264-3446 and is authorized under FDA application NDA206056.

Identification & Billing

NDC Package Code
0264-3446-11
Package Description
24 CONTAINER in 1 CASE / 50 mL in 1 CONTAINER
Product Code
11-Digit Billing Format
00264344611
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1659131 - piperacillin / tazobactam 2.25 GM Injection
  • RxCUI: 1659131 - piperacillin 2000 MG / tazobactam 250 MG Injection
  • RxCUI: 1659131 - piperacillin (as piperacillin sodium) 2000 MG / tazobactam (as tazobactam sodium) 250 MG Injection
  • RxCUI: 1659137 - piperacillin / tazobactam 3.375 GM Injection
  • RxCUI: 1659137 - piperacillin 3000 MG / tazobactam 375 MG Injection

Clinical Specifications

Proprietary Name
Piperacillin And Tazobactam And Sodium Chloride
Non-Proprietary Name
Piperacillin And Tazobactam And Sodium Chloride
Substance Name
Piperacillin Sodium; Tazobactam Sodium
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Usage Information
The usual total daily dosage of Piperacillin and Tazobactam for Injection and Sodium Chloride Injection for adult patients with indications other than nosocomial pneumonia is 3.375 g every 6 (six) hours, to be administered by intravenous infusion over 30 minutes. The usual duration of Piperacillin and Tazobactam for Injection and Sodium Chloride Injection treatment is from 7 to 10 days.

Regulatory & Marketing

Labeler Name
B. Braun Medical Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA206056
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-30-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0264-3446-11 identifies a specific commercial package of 24 container in 1 case / 50 ml in 1 container of Piperacillin And Tazobactam And Sodium Chloride, a human prescription drug labeled by B. Braun Medical Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, solution is formulated for intravenous use and contains piperacillin sodium; tazobactam sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B. Braun Medical Inc. on September 30, 2025. The current certification is valid through December 31, 2027.

How is this B. Braun Medical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00264344611. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0264-3446-11
11-Digit CMS (5-4-2)
00264-3446-11

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.